Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP‐C Treatment as Prevention Study in Prisons
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32002
Abstract: Between 2014 and 2019, the SToP‐C trial observed a halving in HCV incidence in four Australian prisons following scale‐up of direct‐acting antiviral (DAA) therapy. However, the contribution of HCV treatment to this decline is unclear… read more here.
Keywords: treatment; study; evaluating prevention; prevention ... See more keywords